TecEx Medical’s Import Tax Solution
Pharma sponsors waste money treating import taxes as unavoidable sunk costs. TecEx Medical’s IOR expertise unlocks major savings via VAT reclaims and tariff optimization. Ultimately, proactive tax structuring turns import expenses into a repeatable cost-saving strategy.
TecEx Medical’s Import Tax Solution
Sponsors often leave significant value on the table when importing and exporting clinical trial materials globally. Import Tax is frequently treated as a fixed, unavoidable cost and absorbed as a sunk cost.
Partnering directly with specialized Importer of Record (IOR) and tax experts can unlock efficiencies that CRO-managed models often miss. In many jurisdictions, exemptions, deferments, VAT reclaims, and favorable tariff treatments are available, but accessing them requires specialist regulatory and tax expertise.
This case study shows how TecEx Medical, acting as the IOR, can reduce costs through duties and tax optimization, deferments, and VAT reclaims. Sponsors often absorb the full cost of duties and taxes as pass-through expenses when working with other vendors or clearing agents. By partnering with TecEx Medical, sponsors gain both IOR support and access to tax-efficient structures that can improve VAT recovery.
How Outsourcing IOR/EOR Risks Unrecovered Import VAT
Pharma sponsors frequently outsource IOR and EOR responsibilities to Contract Manufacturing Drug Organizations (CMDOs) to manage trade costs and streamline import VAT savings. However, this often creates supply chain confusion, leading companies to absorb duties and taxes as sunk costs rather than recover them.
Role of the CDMO
- Manufacture clinical trial materials on behalf of the sponsor.
- Manage logistics and freight from origin to destination.
- Handle IOR and VAT-related costs.
- Pass these costs back to the sponsor for absorption.
This can create supply chain complexity and cause potential savings to be overlooked rather than recovered.
“Reducing import VAT is one of the most often overlooked and powerful levers to bring down per-patient costs in global clinical trials”
- Matthew Bray (Partnership Manager)
What the Import VAT Solution Looks Like
TecEx Medical handles all duties and taxes, navigating every country’s local laws, administrative paths, and available tax relief options for you. This approach reduces upfront cash outlay and limits non-recoverable tax exposure.
Key mechanisms include:
- VAT Deferment – In countries where TecEx holds deferment licenses, import VAT is not paid at clearance, removing upfront liability and avoiding VAT-reclaim delays.
- VAT Reclaim – Where permitted, TecEx submits all required documentation to recover VAT/GST paid at import, ensuring full, compliant recovery.
- HTS Code Exception / Reduction – Correct, regulation-aligned tariff classifications were applied to reduce duty exposure in key markets.
Together, these mechanisms reduced the client’s fiscal exposure from $8 million to $7 million, generating $1,2 million in savings (15.3%).
This case demonstrates how targeted IOR and VAT structuring can materially reduce global import tax exposure.
Managing multi-country trial supply chains shouldn’t mean losing your budget to administrative friction or unrecoverable taxes. While chasing VAT refunds manually often leads to wasted time, a proactive, expert-designed import strategy changes the game. By structuring your supply chain for tax efficiency early on, you transform VAT from a financial risk into an optimized, repeatable process, ensuring your clinical timelines stay on track and your budget stays intact.
Start the Conversation
Get in touch today, so we can better understand the details of your clinical trial import needs. We can then present a bespoke import structuring solution that suits your needs.
Let us shoulder the complexities of your global clinical trial imports so you can focus on delivering better patient outcomes. It might just be the most impactful thing you do for the long-term success of your clinical trials.
Surely that’s worth a conversation?
Ecovadis